Cargando…
High sensitive detection of circulating tumor cell by multimarker lipid magnetic nanoparticles and clinical verifications
Tumor cells with heterogeneity and diversity can express different markers. At present, positive separation of circulating tumor cells (CTC) taking EpCAM as the marker was used in most cases which could be one-sided, while this study successfully prepared four antibody-modified magnetic immunoliposo...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6876097/ https://www.ncbi.nlm.nih.gov/pubmed/31767014 http://dx.doi.org/10.1186/s12951-019-0548-1 |
_version_ | 1783473154740453376 |
---|---|
author | Chen, Jingde Chen, Lin Du, Shibin Wu, Jing Quan, Ming Yin, Hua Wu, Yin Ye, Xuanting Liang, Xiaofei Jiang, Hong |
author_facet | Chen, Jingde Chen, Lin Du, Shibin Wu, Jing Quan, Ming Yin, Hua Wu, Yin Ye, Xuanting Liang, Xiaofei Jiang, Hong |
author_sort | Chen, Jingde |
collection | PubMed |
description | Tumor cells with heterogeneity and diversity can express different markers. At present, positive separation of circulating tumor cells (CTC) taking EpCAM as the marker was used in most cases which could be one-sided, while this study successfully prepared four antibody-modified magnetic immunoliposomes (MIL) by using the self-assembled liposome with antibody derivatives. This study aims to explore the separation efficiency and clinical detection feasibility of single or combined use of MIL with multi-tumor markers on different tumors. Captured CTC were stained with CK-FITC, CD45-PE and DAPI, and fluorescence microscope was used for the observation, analysis and calculation. The result indicated that the CTC number positive rate in blood samples of four different magnetic balls on the same patient could be up to 87.5% in 32 patients with 14 different kinds tumors. While the effect of directly mixed separation by four kinds of magnetic balls was not satisfying. It suggested that the MIL of multi-tumor markers could be a powerful tool for CTC separation in application of tumor screening and prognosis. |
format | Online Article Text |
id | pubmed-6876097 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-68760972019-11-29 High sensitive detection of circulating tumor cell by multimarker lipid magnetic nanoparticles and clinical verifications Chen, Jingde Chen, Lin Du, Shibin Wu, Jing Quan, Ming Yin, Hua Wu, Yin Ye, Xuanting Liang, Xiaofei Jiang, Hong J Nanobiotechnology Review Tumor cells with heterogeneity and diversity can express different markers. At present, positive separation of circulating tumor cells (CTC) taking EpCAM as the marker was used in most cases which could be one-sided, while this study successfully prepared four antibody-modified magnetic immunoliposomes (MIL) by using the self-assembled liposome with antibody derivatives. This study aims to explore the separation efficiency and clinical detection feasibility of single or combined use of MIL with multi-tumor markers on different tumors. Captured CTC were stained with CK-FITC, CD45-PE and DAPI, and fluorescence microscope was used for the observation, analysis and calculation. The result indicated that the CTC number positive rate in blood samples of four different magnetic balls on the same patient could be up to 87.5% in 32 patients with 14 different kinds tumors. While the effect of directly mixed separation by four kinds of magnetic balls was not satisfying. It suggested that the MIL of multi-tumor markers could be a powerful tool for CTC separation in application of tumor screening and prognosis. BioMed Central 2019-11-25 /pmc/articles/PMC6876097/ /pubmed/31767014 http://dx.doi.org/10.1186/s12951-019-0548-1 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review Chen, Jingde Chen, Lin Du, Shibin Wu, Jing Quan, Ming Yin, Hua Wu, Yin Ye, Xuanting Liang, Xiaofei Jiang, Hong High sensitive detection of circulating tumor cell by multimarker lipid magnetic nanoparticles and clinical verifications |
title | High sensitive detection of circulating tumor cell by multimarker lipid magnetic nanoparticles and clinical verifications |
title_full | High sensitive detection of circulating tumor cell by multimarker lipid magnetic nanoparticles and clinical verifications |
title_fullStr | High sensitive detection of circulating tumor cell by multimarker lipid magnetic nanoparticles and clinical verifications |
title_full_unstemmed | High sensitive detection of circulating tumor cell by multimarker lipid magnetic nanoparticles and clinical verifications |
title_short | High sensitive detection of circulating tumor cell by multimarker lipid magnetic nanoparticles and clinical verifications |
title_sort | high sensitive detection of circulating tumor cell by multimarker lipid magnetic nanoparticles and clinical verifications |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6876097/ https://www.ncbi.nlm.nih.gov/pubmed/31767014 http://dx.doi.org/10.1186/s12951-019-0548-1 |
work_keys_str_mv | AT chenjingde highsensitivedetectionofcirculatingtumorcellbymultimarkerlipidmagneticnanoparticlesandclinicalverifications AT chenlin highsensitivedetectionofcirculatingtumorcellbymultimarkerlipidmagneticnanoparticlesandclinicalverifications AT dushibin highsensitivedetectionofcirculatingtumorcellbymultimarkerlipidmagneticnanoparticlesandclinicalverifications AT wujing highsensitivedetectionofcirculatingtumorcellbymultimarkerlipidmagneticnanoparticlesandclinicalverifications AT quanming highsensitivedetectionofcirculatingtumorcellbymultimarkerlipidmagneticnanoparticlesandclinicalverifications AT yinhua highsensitivedetectionofcirculatingtumorcellbymultimarkerlipidmagneticnanoparticlesandclinicalverifications AT wuyin highsensitivedetectionofcirculatingtumorcellbymultimarkerlipidmagneticnanoparticlesandclinicalverifications AT yexuanting highsensitivedetectionofcirculatingtumorcellbymultimarkerlipidmagneticnanoparticlesandclinicalverifications AT liangxiaofei highsensitivedetectionofcirculatingtumorcellbymultimarkerlipidmagneticnanoparticlesandclinicalverifications AT jianghong highsensitivedetectionofcirculatingtumorcellbymultimarkerlipidmagneticnanoparticlesandclinicalverifications |